Strength Meets Skepticism: IOB's Earnings Momentum vs Market Caution
After a scorching Q1 with 49% profit growth and sharply cleaner NPAs, Indian Overseas Bank reports Q2 FY27 earnings on October 26. The Street remains doubtful on valuation despite the turnaround trajectory.
What to Expect
The headline number that matters: Can IOB sustain the profit momentum from a blockbuster Q1? The bank delivered ₹1,659 Cr net profit in June 2026, a 49% year-on-year surge, on the back of 23.3% total income growth and a sharp 64-basis-point improvement in gross NPAs to 1.33%. For Q2, the Street will be watching whether the bank can hold gains in asset quality while maintaining pricing power amid rate regime changes and continued credit growth.
~₹1,600–1,700 Cr
Q1 baseline ₹1,659 Cr; seasonal patterns and continued pre-provision operating profit leverage expected
~₹3,700–3,800 Cr
Q1 was ₹3,688 Cr; management raising MCLR by 5 bps in mid-October should support steady-state NII
~20–23% YoY
Q1 advances jumped 22.75% to ₹322k Cr; expect sustained momentum into H2 FY27 given capital buffer (CRAR 19.36%)
~1.1–1.3%
Q1 at 1.33%; the swing factor for sentiment. Any tick down signals strong credit discipline; any rise to 1.5%+ is a red flag
Strong print scenario: GNPA stays flat or improves to ~1.1%, net profit lands ₹1,650–1,700 Cr, advances grow 20%+ YoY, and deposit growth holds 12–14% YoY. This would confirm the turnaround is structural, not a one-quarter blip. Weak print scenario: GNPA ticks up to 1.5%+, net profit misses ₹1,550 Cr, deposit growth slows below 10% YoY, or credit growth decelerates sharply (sub-18% YoY). This would raise questions about whether Q1's strong momentum is sustainable or faces headwinds from the bank strike in late September or broader credit tightening.
On Track for Full Year?
IOB has not published explicit FY27 guidance, but the trajectory is clear: H1 FY27 (April–September 2026) will likely show 40%+ profit growth over H1 FY26 on the back of NII momentum and asset quality gains. The bank's ₹5,000 Cr capital raise approved in July signals confidence in growth and strengthens the cushion for continued credit expansion. The 19.36% CRAR in Q1 gives room to grow; a strong Q2 validates the full-year beat narrative the market has yet to price in given the stock's weak 50-week range (₹30.06–₹41.8).
What the Street Says
Since Last Quarter
1 · ESOP Approval (Oct 20, 2026)
SEBI approved a 10-crore equity share issuance under an Employee Stock Purchase Scheme. Bullish signal on employee retention and long-term value creation; routine process but shows management confidence.
2 · MCLR & EBLR Hikes (Oct 7–12, 2026)
Overnight MCLR raised 5 bps to 7.95% (Oct 12), EBLR/RLLR raised to 8.35% (Oct 8). Follows tight RBI policy stance; benefits NII on fresh borrowing but may slow credit growth if transmission incomplete.
3 · Trading Window Closure (Sep 28–Oct 2, 2026)
Closed for Q2 results disclosure. Routine insider-trading blackout; no surprise.
4 · Bank Strike Threat (Sep 25–30, 2026)
United Forum of Bank Unions proposed a 3-day strike. Operations continued, but any disruption to credit underwriting or collection cycles could show up in Q2 metrics. Watch for commentary on impact in the call.
5 · Senior Management Changes (Jul 1, 2026)
Chief General Manager and Chief Compliance Officer elevated; signal of succession planning and governance strengthening. Neutral operationally but positive for long-term stability.
Three Things to Watch on Result Day
1. GNPA trajectory: The engine of the bull case. If the ratio falls below 1.1%, it confirms asset quality has turned a corner. If it rises above 1.5%, Q1 was likely a one-off and concerns about credit cycle peak will resurface. 2. Management guidance on FY27 profit and credit growth: Listen closely to any forward commentary on credit offtake, NIM resilience given MCLR hikes, and deposit mobilization. The ₹1 billion foreign deposit raise target (announced earlier) will indicate how much confidence management has in wholesale funding and international expansion. 3. Cost-to-income ratio and operating leverage: Q1 showed strong pre-provision profit growth (+14.2% YoY). Watch whether this leverage continues as the bank scales or whether loan loss provisions bite harder in Q2.
IOB enters Q2 results with strong Q1 momentum and a cleaner balance sheet, but the Street remains in full 'show me' mode, with consensus targets suggesting the turnaround is not yet believed. The bank reports on October 26; the key is whether Q2 proves the momentum is structural or a seasonal blip. GNPA, credit growth, and management guidance will determine whether the stock finally breaks out of its 50-week range or continues to drift.
IOB Q2 FY27: Consol PAT +56% YoY to ₹1,963 Cr on margin expansion; CRAR dips on RBI flag
PAT +55.91% YoY · revenue +17.2% · margins expanding · beat vs street
₹9,201.23 Cr
+17.2% YoY
₹1,962.67 Cr
+55.91% YoY
18.82%
+5.5pp YoY
₹1.02
Indian Overseas Bank's consolidated net profit for Q2 FY27 rose 55.9% YoY to ₹1,962.67 Cr (from ₹1,258.82 Cr in Q2 FY26) and 14.4% QoQ (from ₹1,716.29 Cr in Q1 FY27), comfortably clearing our pre-result preview's expected ₹1,600–1,700 Cr band and beating the implied Street bar — notable given analyst ratings on the stock skewed SELL (2 strong sell, 3 sell, 2 hold, 0 buy per our preview) on valuation grounds rather than earnings doubts. Net interest income (interest earned less interest expended) came in at ₹3,866.98 Cr, above the preview's ₹3,700–3,800 Cr expectation. NPM expanded to 18.82% from 15.69% QoQ and 13.66% YoY, and OPM to 28.93% from 24.62% QoQ and 26.06% YoY — both YoY and sequential expansion, consistent with a genuine margin story rather than a one-quarter blip.
Q2 FY-2027 vs prior quarters
The margin bridge is mixed on the income side but clean on costs. Interest earned (revenue) grew 17.2% YoY and 4.83% QoQ to ₹9,201.23 Cr, but other income fell to ₹1,226.65 Cr — down 43.2% sequentially from an elevated ₹2,160.23 Cr in Q1 and down 10.2% YoY — leaving total income actually 4.66% lower QoQ at ₹10,427.88 Cr. Profit still rose sequentially because total expenditure (excluding provisions) fell 10.1% QoQ to ₹7,411.39 Cr, driven mainly by employee costs nearly halving to ₹883.96 Cr from ₹2,104.45 Cr in Q1 — likely reflecting a high wage/pension-provision base in the June quarter rather than a new cost baseline, though the filing's notes don't spell this out explicitly. Provisions & contingencies rose to ₹950.08 Cr from ₹834.03 Cr QoQ.
The stock went into the print at ₹29.84, down 7.1% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 5 consecutive quarters.
What the summary numbers don't show
EPS (consolidated) ₹1.02 vs ₹0.89 QoQ vs ₹0.65 YoY
FY27 credit growth 13-14% minimum (actual 22.75%). NIM maintained 3.3-3.4% range (came in 3.37% global). CAR 19.36% comfortable for equity raise Q3-Q4.
— This quarter: beat
On guidance, management's FY27 credit-growth floor of 13–14% is being beaten (22.75% YoY per the bank's own Q1 run-rate disclosure, not separately re-stated this quarter), and NIM has tracked inside the guided 3.3–3.4% band. Capital adequacy is the one area where the quarter cuts against the prior confident framing: standalone CRAR slipped to 18.60% (CET1 16.26%) from 19.36% in Q1, and this comes days after the bank disclosed (Oct 24) that an RBI inspection flagged RWA discrepancies impacting CRAR — a direct, numbered link between a disclosed regulatory finding and the capital ratio move. That lands alongside SEBI's Oct 20 nod for a 10 Cr-share ESPS issuance, which is the equity-raise route management had flagged as comfortable off the (higher) 19.36% base. Standalone gross NPA improved to 1.19% from 1.83% YoY and 1.33% QoQ, squarely inside the preview's 1.1–1.3% expected band — asset quality is not the concern here. No separate management press release was available in our records to cross-check against the filing's own framing.
W1
Whether standalone CRAR stabilizes or extends its slide from 18.60% after the RBI's RWA-discrepancy finding, and whether the 10 Cr-share ESPS equity raise completes in Q3-Q4 as the offset
W2
Whether employee/opex costs stay near Q2's ₹883.96 Cr run-rate or revert toward Q1's ₹2,104.45 Cr level
W3
Whether gross NPA holds near 1.19% (inside the 1.1–1.3% watched band) through Q3
Figures in Lakhs, converted /100 to Cr. No exceptional items (row=0) either period. Consolidated PAT (₹1,962.67 Cr) exceeds PBT-tax (₹1,912.42 Cr) by ₹50.25 Cr — share of profit from associates (Odisha Gramin Bank 35%, ACER Credit Rating 26%), per filing line 13. Standalone CAR fell to 18.60% (CET1 16.26%) from 19.36% in Q1 FY27; consolidated CAR cells blank in filing.